CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Sigma-Aldrich

For profit

Also known as: Sigma-Aldrich

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jan 11, 2017

Last known activity

Dec 15, 2022

Acquired by Merck KGaA → Merck Serono on Jan 1, 2014

Timeline

1970s

  1. Jan 1, 1975

    Sigma-Aldrich— Founded

  2. Jan 1, 1975

    Aldrich— Acquired

  3. Jan 1, 1975

    Sigma Chemical Company— Acquired

2000s

  1. Jan 1, 2001

    Isotec— Acquired

  2. Jan 1, 2004

    Ultrafine— Acquired

  3. Jan 1, 2005

    Degussa— Acquired

  4. Jan 1, 2005

    JRH Biosciences— Acquired

  5. Jan 1, 2006

    Merck Serono— Now

  6. Jan 1, 2006

    Advanced Separation Technologies— Acquired

  7. Jan 1, 2006

    Beijing Superior Chemicals and Instruments Co— Acquired

  8. Jan 1, 2006

    Iropharm— Acquired

  9. Jan 1, 2006

    Pharmorphix— Acquired

  10. Jan 1, 2007

    Epichem Group— Acquired

  11. Jan 1, 2007

    Molecular Medicine BioServices— Acquired

2010s

  1. Jan 1, 2012

    BioReliance— Acquired

  2. Jan 1, 2014

    Merck KGaA— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (13 direct, 20 total across the full acquisition tree)

Recent trials (2)

Details

Founded
St Louis, MO, US Jan 1, 1975
Last known activity
Dec 15, 2022